Dextran 75
Dosage form: injection, powder, lyophilized, for solution
Drug class:Plasma expanders
Medically reviewed by Drugs.com. Last updated on Jun 21, 2021.
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Dear Medical Professional,
Per your order, we have compounded Dextran 75 as a lyophilized powder for injection. The characteristics of this preparation are as follows:
Dextran 75 Description
AnazaoHealth supplies compounded Dextran 75 for the preparation of Tc-99m Dextran 75. Each reaction vial contains 10 mg of Dextran 75, 0.30mg of stannous chloride, 0.73 mg Sodium Citrate and 1 mg of dextrose (lyophilized mixture, under nitrogen atmosphere), per unit dose vial.
Mechanism of Action
Dextran, when labeled with technetium Tc99m and given intravenously, is distributed throughout the body in much the same way as the patient’s serum, and serves as a suitable tracer with which to transiently image the vascular compartment
Indications and Usage for Dextran 75
Technetium Tc99m Dextran by intravenous administration is indicated as a cardiac blood pool imaging agent and as an adjunct in the diagnosis of pericardial effusion, ventricular aneurysm, or GI Bleed
Dextran 75 Dosage and Administration
To prepare injection, up to 40 mCi of an oxidant-free sodium pertechnetate Tc 99m solution is aseptically injected into the vial, minimum volume 1ml, mix gently and let Dextran dissolve completely for 10 minutes
Storage and Handling
Injection should be administered within 6 hours after preparation. Before and after reconstitution- Store at room temperature
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Figure 1
| Dextran 75 Dextran 75 injection, powder, lyophilized, for solution | ||||||||||||
| ||||||||||||
